The governor of New York has said that rising cases of measles constitute a "statewide disaster emergency," the first such ...
Click Therapeutics has won the first-ever FDA approval for a treatment for the negative symptoms of schizophrenia – a digital ...
As antibody-drug conjugates (ADCs) continue to establish themselves as a cornerstone of modern oncology, breakthrough ...
AstraZeneca's pivot towards the US market has continued with the opening of a new R&D centre in the biotech hotspot of ...
This is not simply a broader role for Market Access. It is an emerging leadership capability for the healthcare business.
Industry is using AI to surface hidden patterns and accelerate decision-making in high-pressure launch environments. In a new ...
When pharmaphorum last spoke with MRM Health founder and CEO Sam Possemiers at JP Morgan, he told us about his company’s microbiome-based therapy for ulcerative colitis. At LSX USA in Boston last ...
The UK government has said it will accept all 44 recommendations made in a recently published report on using AI tools in the NHS, including continual monitoring after deployment. This morning, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results